BNB Plus Corp. (BNBX)
OTCMKTS · Delayed Price · Currency is USD
0.1400
+0.0050 (3.70%)
At close: Aug 19, 2026
BNB Plus Financials Overview
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 2.39 | 2.14 | 2.11 | 13.37 | 18.17 | 9.03 |
Revenue Growth | -1.27% | 1.11% | -84.19% | -26.43% | 101.25% | 367.40% |
Gross Profit Gross Profit Growth | 1.42 | 0.84 | 0.97 | 5.53 | 5.05 | 4.48 |
Operating Income Operating Income Growth | -32 | -13.35 | -13.67 | -10.95 | -13.97 | -12.53 |
Net Income Net Income Growth | -66.16 | -69.49 | -7.23 | -9.95 | -8.38 | -14.29 |
Earnings Per Share EPS Growth | -11.91 | -134.23 | - | - | - | - |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Dna Tagging and Security Products and Services Dna Tagging and Security Products and Services Growth | 1.15 | 1.22 | 1.15 | 1.57 | 1.73 |
Therapeutic Dna Production Services Therapeutic Dna Production Services Growth | 0.99 | 0.9 | 1.07 | 0.44 | 0.56 |
Total Total Growth | 2.14 | 2.11 | 13.37 | 18.17 | 9.03 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 3.76 | 1.67 | 5.85 | 7.15 | 15.22 | 6.55 |
Total Debt Total Debt Growth | - | 0.19 | 0.74 | 1.24 | - | - |
Net Cash (Debt) Net Cash Growth | 3.76 | 1.47 | 5.11 | 5.91 | 15.22 | 6.55 |
Net Cash Growth | -14.38% | -71.16% | -13.54% | -61.13% | 132.12% | 20.48% |
Net Cash Per Share Net Cash Per Share Growth | 0.68 | 2.85 | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -11.77 | -12.52 | -13.71 | -6.22 | -8.98 | -13.39 |
Capital Expenditures CapEx Growth | - | -0.31 | -0.41 | -1.14 | -0.49 | -2.55 |
Free Cash Flow Free Cash Flow Growth | -11.77 | -12.83 | -14.12 | -7.36 | -9.47 | -15.94 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Gross Margin | 59.36% | 39.26% | 46.13% | 41.39% | 27.82% | 49.66% |
Operating Margin | -1336.44% | -624.62% | -646.72% | -81.94% | -76.89% | -138.76% |
Pretax Margin | -1503.85% | -731.92% | -321.17% | -74.98% | -45.52% | -158.16% |
Profit Margin | -2763.31% | -3251.74% | -341.88% | -74.41% | -46.11% | -158.25% |
FCF Margin | -491.55% | -600.48% | -668.06% | -55.05% | -52.10% | -176.53% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Forward PE | - | 196.50 | 196.50 | 196.50 | 196.50 | 196.50 |
PS Ratio | 0.36 | 2.35 | 3.17 | 1.24 | 0.80 | 4.47 |